" /> Interstitial lung disease 2 - CISMeF





Preferred Label : Interstitial lung disease 2;

Symbol : ILD2;

CISMeF acronym : IPF; UIP;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Idiopathic pulmonary fibrosis, familial; Fibrosing alveolitis, cryptogenic; Fibrocystic pulmonary dysplasia; Interstitial pneumonitis, usual; UIP; IPF; Pulmonary fibrosis, idiopathic;

Included titles and symbols : Hamman-rich disease;

Description : Idiopathic pulmonary fibrosis is one of a family of idiopathic pneumonias sharing clinical features of shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees in inflammation, fibrosis, or both on lung biopsy. In some cases, the disorder can be rapidly progressive and characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. Although older studies included several forms of interstitial pneumonia under the term 'idiopathic pulmonary fibrosis,' the clinical label of 'pulmonary pulmonary fibrosis' should be reserved for patients with a specific form of fibrosing interstitial pneumonia referred to as usual interstitial pneumonia (Gross and Hunninghake, 2001). It is estimated that 0.5 to 2.2% of cases of idiopathic pulmonary fibrosis are familial (Marshall et al., 2000). Pulmonary fibrosis can also be a feature in patients with mutations in the TERT (187270) or the TERC (602322) gene; see PFBMFT1 (614742) and;

Inheritance : Autosomal dominant;

Molecular basis : Caused by mutation in the pulmonary-associated surfactant protein A2 gene (SFTPA2, 178642.0001);

Neoplasia : Alveolar cell carcinoma (some); Bronchogenic carcinoma (some); Adenocarcinoma of lung (some);

Prefixed ID : #178500;

Details


You can consult :


Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.